According to Bloomberg pharmaceutical industry, M&As have hit the record volume in 2015
and are valued to reach an astronomic amount of $221 billion US dollars. Life Sciences industry
has been banking on mergers and acquisitions to improve market positioning, expand product
portfolio and invest in new therapeutic areas.